Gene: RIC3
Official Full Name: RIC3 acetylcholine receptor chaperoneprovided by HGNC
Gene Summary: This gene encodes a member of the resistance to inhibitors of cholinesterase 3-like family which functions as a chaperone of specific 5-hydroxytryptamine type 3 receptor and nicotinic acetylcholine receptor subtypes. The encoded protein influences the folding and assembly of these receptor subunits in the endoplasmic reticulum and expression on the cell surface. This protein contains an N-terminal transmembrane domain, a proline-rich spacer, and a cytosolic C-terminal coiled-coil domain. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14548 | RIC3 Knockout cell line (HeLa) | Human | RIC3 | 1:3~1:6 | Negative | Online Inquiry |
KO14549 | RIC3 Knockout cell line (A549) | Human | RIC3 | 1:3~1:4 | Negative | Online Inquiry |
RIC3 Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to functionally study the RIC3 gene, which is critical in the regulation of nicotinic acetylcholine receptors (nAChRs). These knockout cell lines have been meticulously developed to lack functional RIC3 protein, thereby providing a unique platform for examining the role of RIC3 in receptor assembly, trafficking, and function.
The primary function of these cell lines is to facilitate the dissection of molecular pathways that involve nAChRs, which play significant roles in neurotransmission and have implications in numerous neurodegenerative and psychiatric disorders. By utilizing CRISPR/Cas9 technology for precise gene editing, RIC3 Gene Knockout Cell Lines allow researchers to explore the mechanistic underpinnings of cellular response to nicotine and other agonists, illuminating potential therapeutic targets for conditions such as Alzheimer's disease, schizophrenia, and other related disorders.
Scientifically, the RIC3 Gene Knockout Cell Lines are invaluable tools in both basic and translational research settings. Their application can extend to drug discovery, where understanding receptor dynamics can accelerate the development of innovative pharmacological interventions. Furthermore, their usage in functional assays to assess receptor behavior can provide insights into the etiology of various diseases where nAChRs are implicated.
Key advantages of RIC3 Gene Knockout Cell Lines compared to traditional models include higher specificity in gene targeting, reduced off-target effects, and the ability to generate stable cell lines that can be easily propagated for long-term studies. This specificity not only enhances the reliability of experimental outcomes but also offers a streamlined approach to studying gene function without the confounding variables present in less controlled systems.
For researchers and clinicians dedicated to the advancement of neurobiological science, RIC3 Gene Knockout Cell Lines represent a powerful resource with immense research potential. These lines empower users to unlock new knowledge about receptor biology and leverage findings towards clinical solutions.
Our company, with years of experience in molecular genetics and cell biology, is dedicated to providing high-quality, genetically modified cell lines tailored to meet the evolving needs of the scientific community. We focus on innovation and reliability, ensuring our customers have access to the most effective tools for their research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.